Efficient Production of the Dicarboxylic Acid Glutarate by via a Novel Synthetic Pathway.

The dicarboxylic acid glutarate is an important building-block gaining interest in the chemical and pharmaceutical industry. Here, a synthetic pathway for fermentative production of glutarate by the actinobacterium has been developed. The pathway does not require molecular oxygen and operates via lysine decarboyxylase followed by two transamination and two NAD-dependent oxidation reactions. Using a genome-streamlined L-lysine producing strain as basis, metabolic engineering was performed to enable conversion of L-lysine to glutarate in a five-step synthetic pathway comprising lysine decarboxylase, putrescine transaminase and γ-aminobutyraldehyde dehydrogenase from and GABA/5AVA amino transferase and succinate/glutarate semialdehyde dehydrogenase either from or from three species. Loss of carbon via formation of the by-products cadaverine and -acetylcadaverine was avoided by deletion of the respective acetylase and export genes. As the two transamination reactions in the synthetic glutarate biosynthesis pathway yield L-glutamate, biosynthesis of L-glutamate by glutamate dehydrogenase was expected to be obsolete and, indeed, deletion of its gene increased glutarate titers by 10%. Glutarate production by the final strain was tested in bioreactors ( = 2) in order to investigate stability and reliability of the process. The most efficient glutarate production from glucose was achieved by fed-batch fermentation ( = 1) with a volumetric productivity of 0.32 g L h, an overall yield of 0.17 g g and a titer of 25 g L.